NGS platform to generate additional clinical data to build out the Skyline-Helomics D-CHIP bioinformatics platform MINNEAPOLIS — Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today announced that it is expanding into Next Generation Sequencing (“NGS”) through the licensing of an NGS platform MiSeqDx®, from Illumina. […]
ArcticZymes today announced the expansion of their polymerase portfolio. The IsoPol™ SD⁺ and IsoPol™ BST⁺ deliver low temperature isothermal polymerases, one with increased strand displacement, and the second an improvement over existing Bacillus stearothermophilus available today. IsoPol™ SD+ is a DNA polymerase with stronger strand displacement activity, and higher salt tolerance compared to ArcticZymes first […]
— Aims to accelerate manufacturing of new treatments for broad range of serious diseases — Underscores MilliporeSigma as a leading contract manufacturing organization and commercial provider of viral vectors for gene therapy BURLINGTON, Mass. — MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, Massachusetts, for […]
WALTHAM, Mass. — Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher’s Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies. Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 […]
TOKYO – JSR Corporation agreed with Crown Bioscience International (hereinafter “Crown”, Registration: Cayman Islands, CEO:Jean-Pierre Wery, a listed company in TPEx: 6554), which is a contract research organization (“CRO”) providing services to pharmas to support drug development in pre-clinical phases, to acquire 100% ownership of the Company and make it a subsidiary of JSR (the […]
SANTA CRUZ, Calif. — SomaGenics, an RNA-focused biotechnology company, expands its IP protection with three newly issued patents by the United States Patent and Trademark Office covering two of the Company’s core RNA detection technologies: targeted small RNA sequencing (RealSeq®-T) and quantitative PCR analysis of RNA fragments (ResQ®), as well as SomaGenics’ therapeutic sshRNA®s. A patent […]
Epigenetic Markers and Sustained Cytoprotection for Stroke Treatment IRVINE, Calif. — Zymo Research Corp. has been awarded a Phase I Small Business Technology Transfer (STTR) grant from the National Institutes of Health (NIH). The STTR Program requires small businesses to collaborate with a research institution. The program’s goals according to their website are as follows: Stimulate technological innovation. Foster […]
We are happy to announce the release of the new Globin Block Modules for QuantSeq kits. These modules extend the functionality of the QuantSeq 3’ mRNA-Seq Library Prep, for gene expression profiling of whole blood, which is one of the most challenging sample types for transcriptome studies. Blood is a highly informative, fairly low cost, and […]
It is our pleasure to announce that, as of today, Biognosys is providing a Spectronaut™ Pulsar Viewer to the proteomics community. The Spectronaut Pulsar Viewer is currently the only MCP-compliant viewer software for DIA experiments submitted to Molecular & Cellular Proteomics (MCP). The Spectronaut Pulsar Viewer allows researchers to review published DIA data. By providing […]
Potato pangenome research drives cooperation between international public and private sectors Ness Ziona, Israel – NRGene, the worldwide leader in genomic assembly and analysis, is working with a team of researchers from Wageningen University & Research (WUR) in the Netherlands and leading commercial partners to create multi-genome mapping of commercial food potatoes. Potatoes are the fourth […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
